IMP accountability rules mean that participants may not be permitted to carry additional supplies beyond what is authorised by the trial team
[DOI] [PubMed] [Google Scholar] 2.Sikiric P., Drmic D., Sever M., Klicek R., Blagaic A.B., Tvrdeic A., Kralj T., Kovac K.K., Vukojevic J., Siroglavic M., et al
In the U.S., an estimated 5.1% of non-Hispanic White patients with obesity use GLP-1s, compared to 4.5% of Asian patients, 4.1% of non-Hispanic Black patients, 4.0% of Native American patients, and 3.7% of Hispanic patients
But it does add an important nuance: for patients taking GLP-1 medications to manage diabetes (rather than purely for weight loss), there may be a net benefit to gum health IF the other side effects (dry mouth, vomiting, nutritional gaps) are actively managed